Organogenesis Holdings's market cap is currently ―. The company's EPS TTM is $0.125; its P/E ratio is 15.44; Organogenesis Holdings is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 115.52M	$ 116.86M	$ 121.40M	$ 98.12M	$ 128.56M
Gross Profit	$ 88.41M	$ 90.68M	$ 94.75M	$ 73.04M	$ 95.96M
EBIT	$ 8.72M	$ 1.78M	$ 11.91M	$ 869.00K	$ 20.44M
EBITDA	$ 13.28M	$ 6.29M	$ 16.46M	$ 5.28M	$ 25.27M
Net Income Common Stockholders	$ 7.49M	$ 215.00K	$ 8.74M	$ 87.00K	$ 51.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 102.48M	$ 107.25M	$ 112.28M	$ 107.90M	$ 113.93M
Total Assets	$ 449.36M	$ 457.27M	$ 456.36M	$ 436.27M	$ 443.26M
Total Debt	$ 123.79M	$ 130.71M	$ 131.61M	$ 130.19M	$ 132.30M
Net Debt	$ 21.31M	$ 23.46M	$ 19.33M	$ 22.30M	$ 18.37M
Total Liabilities	$ 183.69M	$ 200.94M	$ 201.97M	$ 193.04M	$ 201.22M
Stockholders Equity	$ 265.67M	$ 256.33M	$ 254.38M	$ 243.23M	$ 242.03M
Cash Flow	-
Free Cash Flow	$ -2.86M	$ -4.95M	$ 4.03M	$ -5.26M	$ 12.72M
Operating Cash Flow	$ 7.80M	$ 5.45M	$ 10.20M	$ 1.41M	$ 17.95M
Investing Cash Flow	$ -10.66M	$ -10.40M	$ -6.17M	$ -6.67M	$ -5.23M
Financing Cash Flow	$ -1.88M	$ 26.00K	$ 415.00K	$ -765.00K	$ -917.00K

Currency in USD

Organogenesis Holdings Earnings and Revenue History

Income Statement >

Organogenesis Holdings Debt to Assets

Balance Sheet >

Organogenesis Holdings Cash Flow

Cash Flow >

Organogenesis Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing